Revisiting the potential role of BCG and MMR vaccines in COVID-19

dc.contributor.authorBayram, Zeina
dc.contributor.authorMusharrafieh, Umayya
dc.contributor.authorBizri, Abdul Rahman N.
dc.contributor.departmentInternal Medicine
dc.contributor.facultyFaculty of Medicine (FM)
dc.contributor.institutionAmerican University of Beirut
dc.date.accessioned2025-01-24T11:43:43Z
dc.date.available2025-01-24T11:43:43Z
dc.date.issued2022
dc.description.abstractDespite the development and deployment of effective COVID-19 vaccines, many regions remain poorly covered. Seeking alternative tools for achieving immunity against COVID-19 remains to be of high importance. “Trained immunity” is the nonspecific immune response usually established through administering live attenuated vaccines and is a potential preventive tool against unrelated infections. Evidence regarding a possible protective role for certain live attenuated vaccines against COVID-19 has emerged mainly for those administered as part of childhood vaccination protocols. This review summarizes the relevant literature about the potential impact of Bacille Calmette–Guérin (BCG) and measles, mumps and rubella (MMR) vaccines on COVID-19. Existing available data suggest a potential role for BCG and MMR in reducing COVID-19 casualties and burden. However, more investigation and comparative studies are required for a better understanding of their impact on COVID-19 outcomes. © The Author(s) 2022.
dc.identifier.doihttps://doi.org/10.1177/00368504221105172
dc.identifier.eid2-s2.0-85131371793
dc.identifier.pmid35848578
dc.identifier.urihttp://hdl.handle.net/10938/30342
dc.language.isoen
dc.publisherSAGE Publications Ltd
dc.relation.ispartofScience Progress
dc.sourceScopus
dc.subjectBcg
dc.subjectCoronavirus
dc.subjectCovid-19
dc.subjectImmunity
dc.subjectMmr
dc.subjectBcg vaccine
dc.subjectCovid-19 vaccines
dc.subjectHumans
dc.subjectMeasles-mumps-rubella vaccine
dc.subjectMumps
dc.subjectRubella
dc.subjectVaccination
dc.subjectVaccines, attenuated
dc.subjectLive vaccine
dc.subjectMeasles mumps rubella vaccine
dc.subjectDrug therapy
dc.subjectHuman
dc.subjectPrevention and control
dc.titleRevisiting the potential role of BCG and MMR vaccines in COVID-19
dc.typeReview

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
2022-1873.pdf
Size:
760.45 KB
Format:
Adobe Portable Document Format